Weight Loss Peptides High Quality 99% Purity Pharmaceutical Chemical Liraglutide Powder CAS 204656-20-2
Model NO.
CAS 204656-20-2
Colour
White
Name
Liraglutide
Mf
C172h265n43o51
MW
3751.202
CAS
810-818-7
Packing
1kg/Foil Bag or 25kgs/Drum
Usage
for Research Use Only
Transport Package
as Customer′s Requirement
Specification
1G/Foil bag
Trademark
Redgia
Origin
China
Reference Price
$ 765.00 - 900.00
Description
Product Description
Weight Loss Peptides 99% Purity Pharmaceutical Chemical Liraglutide Powder CAS 204656-20-2
Decription
| Product name | Liraglutide |
| Appearance | White powder |
| Purity | 99% |
| Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
| Shelf Life | 24 Months |
Decription
Liraglutide (NN2211) is a long-acting gluca on-like peptide-1 receptor agonist, binding to the same receptors as
does the endogenous metabolic hormone GLP-1 that stimulates insuli secretion. Marketed under the brand name
Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo
Nordisk began marketing it in the U.S. under the brand name Saxend-a as a treatment for obesity in adults with at
least one weight-related comorbid condition.
Liraglutide was approved for treatment of type 2 diabetes by the European Medicines Agency (EMA) on July 3,
2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010. More recently, Liraglutide was
approved by the FDA on December 23, 2014 for treatment for obesity in adults with some related comorbidity.
does the endogenous metabolic hormone GLP-1 that stimulates insuli secretion. Marketed under the brand name
Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo
Nordisk began marketing it in the U.S. under the brand name Saxend-a as a treatment for obesity in adults with at
least one weight-related comorbid condition.
Liraglutide was approved for treatment of type 2 diabetes by the European Medicines Agency (EMA) on July 3,
2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010. More recently, Liraglutide was
approved by the FDA on December 23, 2014 for treatment for obesity in adults with some related comorbidity.
Application&Function
Liraglutide is a once-daily injectable derivative of the human incretin glucagon-like peptide-1 (GLP-1), for the
treatment of type
2 diabetes or obesity.
1.Treating type 2 diabetes.
2.Treating obesity.
Organic Intermediate
-
99% Ghk-Cu Copper Peptide Finasteride Dutasteride USA 4-7days Domestic Delivery CAS: 49557-75-7
Manufacturer Supply High Purity CAS 5466-77-3 Octinoxate, Suncream / Octyl 4-Methoxycinnamate
CAS 38304-91-5 98% Hair Regrowth API Raw Material Minoxidil
99.5% Hexafluoroisopropanol CAS No 920-66-1
Lysipressin CAS 50-57-7 Manufacturer and Supplier
CAS 72-40-2 Manufacturer and Supplier
Factory Supply 5-Aminolevulinic Acid HCl CAS 5451-09-2
CAS 54-20-6 Manufacturer and Supplier
Hair Treatment Powder Finasteride CAS 98319-26-7 Ship to USA European Australia Brzail
Artemisinin CAS 63968-64-9 Manufacturer and Supplier
Good Price 5-Ala 5-Aminolevulinic Acid CAS 106-60-5 for Agricultural Use
Anabolic Hormone Raw Powder Cyp for All Bodybuildiers
Octapeptide-2 Manufacturer and Supplier
Factory Customized Rogaine Spray Minoxidil Max Promote Hair Regrowth Middle East Wholesales CAS: 38304-91-5
Pure 5-Ala 5-Aminolevulinic Acid Hydrochloride CAS 5451-09-2 5-Aminolevulinic Acid HCl
CAS 166896-74-8 Finasteride Intermediate / 17b- (TERT-BUTYLCARBAMOYL) -4-Aza-5A-Androsten-3-One / F8 / Finasteride Impurity 5